Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 171Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Um enfoque mais amplo para o Jornalismo Científico
Carlos Henrique Fioravanti
Intercom: Revista Brasileira de Ciências da Comunicação.2013;36(2)315
[DOI]
2Clinical Trial Regulations in India: Progress and Challenges Arising from Recent Amendments to Schedule Y of the Drugs and Cosmetics (D&C) Act 1940 (D&C Rules 1945)
Amit Kondal,G. V. Murali Krishna,Dipika Bansal
Pharmaceutical Medicine.2016;30(1)1
[DOI]
3PARTAKE Survey of Public Knowledge and Perceptions of Clinical Research in India
Tal Burt,Savita Dhillon,Pooja Sharma,Danish Khan,Deepa MV,Sazid Alam,Sarika Jain,Bhavana Alapati,Sanjay Mittal,Padam Singh,David Joseph Diemert
PLoS ONE.2013;8(7)e68666
[DOI]
4Awareness and Opinions of Research Professionals on India's New Drug and Clinical Trials Regulations: Protocol for a Cross-Sectional Web-Based Survey Study
Vishal Vennu,Saurabh Dahiya
JMIR Research Protocols.2020;9(1)e14744
[DOI]
5Recent Changes to Clinical Trial Regulation in India: Focus on Serious Adverse Events, Compensation and Registration of Ethics Committees
Manoj Karwa,Saurabh Arora,Shilpa Garg Agrawal
Pharmaceutical Medicine.2013;27(5)283
[DOI]
6Solving clinical trial delays: innovative solutions
Kavita Singh,M Abdul Salam,Raji Devarajan,Dorairaj Prabhakaran
Clinical Investigation.2015;5(9)745
[DOI]
7Compensation for Clinical Trial-Related Injury and Death in India: Challenges and the Way Forward
Yogendra Kumar Gupta,Arun Kumar Pradhan,Aman Goyal,Prafull Mohan
Drug Safety.2014;37(12)995
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal